ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 46

$1.56M Total Retail Price of All Prescriptions

Rank: 1 out of 46

1,710 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,710 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 17,478 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
WARFARIN SODIUM 1,710 1,359 1 11
CARVEDILOL 1,710 1,191 10 1 2
CLOPIDOGREL 1,480 1,141 10 3 3
DIGOXIN 1,421 1,131 10 4 13
ISOSORBIDE MONONITRATE ER 1,400 975 10 5 9
LISINOPRIL 1,172 784 6 1
PLAVIX 1,128 863 10 7 10
FUROSEMIDE 953 726 8 4
METOPROLOL SUCCINATE 682 538 9 5
PRAVASTATIN SODIUM 590 437 10 14
AMLODIPINE BESYLATE 515 446 11 7
POTASSIUM CHLORIDE 459 325 12 16
ATORVASTATIN CALCIUM 459 363 12 12
ATENOLOL 448 324 14 17
SIMVASTATIN 429 356 15 8
NIASPAN 427 290 16 27
METOPROLOL TARTRATE 427 368 16 6
NITROSTAT 382 251 18 20
CRESTOR 360 264 19 15
SOTALOL 342 294 20 29
SPIRONOLACTONE 338 204 21 21
ZETIA 309 217 22 25
LOSARTAN POTASSIUM 247 189 23 19
CILOSTAZOL 226 158 24 34
EFFIENT 218 175 25 22
KLOR-CON M20 207 139 26 31
OMEPRAZOLE 180 120 27 28
DIOVAN 173 116 28 33
VERAPAMIL ER 167 143 29 39
VYTORIN 161 120 30 59
RAMIPRIL 152 131 31 23
ENALAPRIL MALEATE 147 105 32 36
PROPAFENONE HCL 143 111 33 52
PANTOPRAZOLE SODIUM 141 96 34 42
CLONIDINE HCL 132 95 35 50
QUINAPRIL HCL 122 64 36 82
FENOFIBRATE 120 92 37 40
BYSTOLIC 117 69 38 30
HYDROCHLOROTHIAZIDE 115 72 39 18
RANITIDINE HCL 111 67 40 54
FLECAINIDE ACETATE 111 91 40 63
LOVASTATIN 110 105 42 61
LOVAZA 107 80 43 55
MULTAQ 103 103 44 45
NITROGLYCERIN PATCH 101 82 45 41
ISOSORBIDE DINITRATE 75 66 46 47
NEXIUM 73 49 47 51
AMLODIPINE BESYLATE-BENAZEPRIL 72 52 48 77
LANOXIN 68 59 49 71
RANEXA 67 39 50 24
HYDRALAZINE HCL 65 47 51 38
TICLOPIDINE HCL 63 63 R 52 111
DILTIAZEM 24HR ER 62 41 53 57
COUMADIN 58 48 54 113
TRIAMTERENE-HCTZ 55 37 55 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 40 56 35
TRICOR 52 33 57 48
MEXILETINE HCL 51 42 58 120
DILTIAZEM 24HR CD 51 47 58 37
NISOLDIPINE 50 40 60 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.